Product
ubenimex
Aliases
UBX
3 clinical trials
2 indications
Indication
Pulmonary Arterial HypertensionIndication
LymphedemaClinical trial
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)Status: Completed, Estimated PCD: 2017-11-01
Clinical trial
Ubenimex in Adult Patients With Lymphedema of The Lower Limb: a Phase 2, RAndomized, Double-blind, Placebo-controlled Study of Efficacy, Safety, and Pharmacokinetics (ULTRA)Status: Completed, Estimated PCD: 2018-10-01
Clinical trial
A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)Status: Terminated, Estimated PCD: 2018-03-01